Why the Biomedical 'Crisis' Really Isn't

Biomedical researchers argue that they're being starved for funding. But the problems are largely of their own making

The nation's biomedical research enterprise is in a serious crisis, says a new report from America's top universities. Because of shortfalls in funding from the National Institutes of Health (NIH), only 20% of the projects submitted for funding are being supported. Researchers are spending more time writing grants than doing science. Brilliant young investigators are leaving science in frustration. And the historic U.S. lead in biotech is threatened, said Dr. Edward Miller, chief executive officer of Johns Hopkins Medicine and dean of the university's School of Medicine, at a Mar. 19 Senate briefing on the new report. "It is a disaster," he says.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.